|
AKTS Aktis Oncology Inc 2035832 |
| Balance Sheet |
|
Current Assets
|
$543,940,000.00 |
|
Assets
|
$576,801,000.00 |
|
Current Liabilities
|
$27,913,000.00 |
|
Liabilities
|
$70,693,000.00 |
|
Equity
|
$506,108,000.00 |
|
Shares Out
|
53403173.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-24,242,000.00 |
|
Investing Cash Flow
|
$20,541,000.00 |
| Market Analysis |
Market Cap
|
$1,228,272,979.00 |
|
Price
|
$21.82 |
|
BVPS
|
9.48 |
|
PB
|
2.43 |
|
EPS
|
-0.38 |
|
PS
|
131.40 |
|
FCF
|
$-26,096,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:20 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AKTS documents filed with the SEC.
AKTS Filings
Clear
